MedTrace Logo

Bupivacaine 5 mg vs 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population

NCT03834454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2019-02-11

No results posted yet for this study

Summary

This study aims to evaluate the efficacy of hyperbaric 5 mg bupivacaine + fentanyl 25 mcg versus hyperbaric 7.5 mg bupivacaine + fentanyl 25 mcg to lower incidence of hypotension

Conditions

  • Cesarean Section
  • Hypotension Drug-Induced
  • Spinal Anesthesia
  • Postoperative Complications

Interventions

DRUG

Bupivacaine

5 mg hyperbaric bupivacaine 0.5% and 25 mcg fentanyl for spinal anesthesia

DRUG

Bupivacaine

7.5 mg hyperbaric bupivacaine 0.5% and 25 mcg fentanyl for spinal anesthesia

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03834454 on ClinicalTrials.gov